VOXZOGO® (vosoritide) is the first and only FDA-approved treatment to increase linear growth for children of all ages with achondroplasia and open growth plates.
Get email updates or get in touch with a local BioMarin representative.
Approved for children of all ages with achondroplasia and open growth plates
VOXZOGO® (vosoritide) is the first and only FDA-approved treatment to increase linear growth for children of all ages with achondroplasia and open growth plates.
Get email updates or get in touch with a local BioMarin representative.
Locate a healthcare provider in your area.
Join us for an event where experts discuss treatment with VOXZOGO.
What is the most important safety information about VOXZOGO?
What are the most common side effects of VOXZOGO?
How is VOXZOGO taken?
What should you tell the doctor before or during taking VOXZOGO?
You may report side effects to BioMarin at 1-866-906-6100. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Please see additional safety information in the full Prescribing Information and Patient Information.
What is VOXZOGO used for?